Trial intelligence / Profile preview

Ranferon iron supplementation after blood donation in Nigeria

PACTR202106811797550Completed

Sponsor
Sun Pharma
Start
Feb 2020
Countries
1
01

Overview

Open-label, single-arm trial in iron deficiency anemia (IDA), sponsored by Sun Pharma. Primary endpoint: Recovery time of haemoglobin levels, red cell indices and iron stores after donation. Started Feb 2020; status: completed.

02

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on PACTR202106811797550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202106811797550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call